← back to search

Manuel Cuenca‐Estrella

Instituto de Salud Carlos III ·
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Antifungal resistance and susceptibility, Fungal Infections and Studies, Plant Pathogens and Fungal Diseases, and Nail Diseases and Treatments.
h-index
80
citations
28,303
works
269
NIH funding
primary concept
Fluconazole
email

Recent publications

Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM
Intensive Care Medicine 2024cited by 160position: middledoi
When to change treatment of acute invasive aspergillosis: an expert viewpoint
Journal of Antimicrobial Chemotherapy 2021cited by 36position: middledoi
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
The Lancet 2020cited by 1,886position: middledoi
Polymorphisms within the TNFSF4 and MAPKAPK2 Loci Influence the Risk of Developing Invasive Aspergillosis: A Two-Stage Case Control Study in the Context of the aspBIOmics Consortium
Journal of Fungi 2020cited by 37position: middledoi
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
Clinical Infectious Diseases 2019cited by 2,757position: middledoi
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients
Intensive Care Medicine 2019cited by 235position: middledoi
Defining standards of CARE for invasive fungal diseases in the ICU
Journal of Antimicrobial Chemotherapy 2019cited by 17position: firstdoi
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
Clinical Microbiology and Infection 2018cited by 1,502position: middledoi
Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors
Transplantation 2018cited by 68position: middledoi
Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the <scp>FUN</scp>gal infections Definitions in <scp>ICU</scp> patients (<scp>FUNDICU</scp>) project
Mycoses 2018cited by 61position: middledoi
ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013
Clinical Microbiology and Infection 2014cited by 853position: middledoi
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others
Clinical Microbiology and Infection 2014cited by 507position: middledoi
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi
Clinical Microbiology and Infection 2014cited by 355position: lastdoi
ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
Clinical Microbiology and Infection 2012cited by 1,211position: middledoi
ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures
Clinical Microbiology and Infection 2012cited by 394position: firstdoi
ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
Clinical Microbiology and Infection 2012cited by 360position: middledoi
ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)
Clinical Microbiology and Infection 2012cited by 335position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Andreas H. Groll · TU Dortmund University5 papers (2012–2021)Matteo Bassetti · Istituto Nazionale di Fisica Nucleare, Sezione di Genova5 papers (2012–2019)Paul E. Verweij · Radboud University Nijmegen5 papers (2012–2021)Olivier Lortholary · Institut Pasteur5 papers (2012–2021)Oliver A. Cornely · Agostino Gemelli University Polyclinic5 papers (2012–2021)J. Peter Donnelly · Baylor College of Medicine5 papers (2012–2021)Andrew J. Ullmann · Johannes Gutenberg University Mainz4 papers (2012–2012)Elio Castagnola · Istituto Giannina Gaslini4 papers (2012–2012)Emmanuel Roilides · The Royal Melbourne Hospital4 papers (2012–2012)Henrik Elvang Jensen · University of Copenhagen4 papers (2012–2012)Raoul Herbrecht · Amgen (United States)4 papers (2012–2012)Sevtap Arıkan-Akdağlı · Hacettepe University4 papers (2012–2012)Malcolm Richardson · Manchester Academic Health Science Centre4 papers (2012–2012)Murat Akova · Hacettepe University Hospital4 papers (2012–2012)William Hope · University of Liverpool4 papers (2012–2012)Cornelia Lass‐Flörl · Innsbruck Medical University4 papers (2012–2012)Bart Jan Kullberg · Radboud University Nijmegen4 papers (2012–2012)Maiken Cavling Arendrup · Statens Serum Institut4 papers (2012–2012)Jacques Billé · University of Lausanne4 papers (2012–2012)Wouter Meersseman · KU Leuven4 papers (2012–2012)